RJFSA
HZNP

Raymond James Financial Services Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Raymond James Financial Services Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,658
Closed -$308K – 3480
2023
Q3 		$308K Sell
2,658
-57
-2% -$6.12K ﹤0.01% 2632
2023
Q2 		$279K Sell
2,715
-383
-12% -$40.4K ﹤0.01% 2703
2023
Q1 		$338K Sell
3,098
-71,537
-96% -$7.91M ﹤0.01% 2571
2022
Q4 		$8.49M Sell
74,635
-1,831
-2% -$152K 0.02% 721
2022
Q3 		$4.73M Buy
76,466
+415
+0.5% +$29K 0.01% 939
2022
Q2 		$6.07M Sell
76,051
-738
-1% -$69.9K 0.01% 837
2022
Q1 		$8.08M Sell
76,789
-13,616
-15% -$1.33M 0.02% 775
2021
Q4 		$9.74M Buy
90,405
+6,971
+8% +$760K 0.02% 696
2021
Q3 		$9.14M Sell
83,434
-1,480
-2% -$154K 0.02% 705
2021
Q2 		$7.95M Buy
84,914
+3,424
+4% +$315K 0.02% 760
2021
Q1 		$7.5M Sell
81,490
-25,622
-24% -$2.16M 0.02% 732
2020
Q4 		$7.83M Buy
107,112
+6,825
+7% +$507K 0.02% 654
2020
Q3 		$7.79M Sell
100,287
-3,158
-3% -$217K 0.02% 591
2020
Q2 		$5.75M Buy
103,445
+1,696
+2% +$72.6K 0.02% 652
2020
Q1 		$3.01M Sell
101,749
-32,861
-24% -$1.11M 0.01% 710
2019
Q4 		$4.87M Sell
134,610
-3,066
-2% -$94K 0.02% 736
2019
Q3 		$3.75M Buy
137,676
+368
+0.3% +$9.52K 0.01% 801
2019
Q2 		$3.3M Buy
137,308
+2,825
+2% +$71.7K 0.01% 851
2019
Q1 		$3.55M Buy
134,483
+41,093
+44% +$974K 0.01% 790
2018
Q4 		$1.82M Buy
+93,390
New +$1.83M 0.01% 955
2015
Q4 		– Sell
-11,757
Closed -$233K – 1651
2015
Q3 		$233K Buy
+11,757
New +$371K ﹤0.01% 1313

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Raymond James Financial Services Advisors's HZNP Position: Q4 2023 in Review

Raymond James Financial Services Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,658 shares — an estimated $308K sold.

Raymond James Financial Services Advisors first reported a position in HZNP in Q3 2015 and held it in 21 quarters. The position peaked at $9.74M in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Raymond James Financial Services Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 2,658 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $308K.
  • Raymond James Financial Services Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 21 quarters.
  • Raymond James Financial Services Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $9.74M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.